Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a primary brain tumour (glioblastoma) or another type of cancer such as breast or lung cancer
- People who are new patients at City of Hope (any location), or who receive at least some of their care at the City of Hope Duarte Campus — this includes procedures, consultations, lab tests, imaging, surgery, or treatment
- People who are in a committed relationship or partnership where their partner is available and willing to take part in the study
- People who speak English or Spanish
- People who are 18 years of age or older
- People who have access to a smartphone, computer, laptop, or internet connection to complete the study activities
Who may not be able to join:
- People with significant difficulties with memory, thinking, or understanding
- People who are currently receiving inpatient psychiatric treatment for a severe mental illness, or who show clear signs of severe mental health conditions such as psychosis
- People whose vision, hearing, speech, or physical movement makes it impossible to complete the study procedures, based on a clinician's assessment
- Partners of participants may not be able to join if they decline to sign the informed consent form, have cognitive impairment, or have a severe mental illness that would prevent them from giving informed consent or completing study activities, based on a clinician's assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accrual rate (AR); Retention rate (RR); Adherence rate (AdR); Study Satisfaction (SS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.